[1]
“Economic Evaluation of FDA-Approved Small Molecule Protein Kinase Inhibitors in Oncology and Non-Oncology Indications in the United States”, Ind-Am. J Life. Sci. Biotech., vol. 20, no. 1, pp. 15–46, Feb. 2023, Accessed: Mar. 07, 2026. [Online]. Available: https://iajlb.org/index.php/iajlb/article/view/210